126
Participants
Start Date
October 31, 2011
Primary Completion Date
January 31, 2016
Study Completion Date
June 30, 2016
Antihypertensive Agents
"Study formulary consists of ACE/ARB, Beta Adrenergic Blocker, Calcium Channel Blocker, vasodilators, peripheral alpha antagonist and central alpha agonist.~ACE I or ARB is first line, the order of addition of subsequent medications is per the discretion of the investigator"
Dry weight Challenge
Reduce the estimated dry weight of the patient's progressively over 2 -week intervals until the dry weight challenge is no longer tolerated or the patient is at BP goal
Extend dialysis treatment time and re-challenge estimated dry weight
Extend dialysis treatment time and re-challenge estimated dry weight
Dialysis Clinic Inc - Oakland, Pittsburgh
Dialysis Clinic Inc - Banksville, Pittsburgh
Dialysis Clinic Inc - Point Breeze, Pittsburgh
Dialysis Clinic Inc - North Hills, Pittsburgh
Dialysis Clinic Inc - Magnolia Court, Charleston
Dialysis Clinic Inc - Azalea Place, North Charleston
Dialysis Clinic Inc - West Ashley, Charleston
Dialysis Clinic Inc - James Island, Charleston
Dialysis Clinic Inc - East Cooper, Mt. Pleasant
Centers for Dialysis Care East, Cleveland
Centers for Dialysis Care - Shaker Heights, Cleveland
Dialysis Clinic Inc - Grants, Grants
Dialysis Clinic Inc - Albuquerque, Albuquerque
Dialysis Clinic Inc - Albuquerque South, Albuquerque
Dialysis Clinic Inc - Albuquerque East, Albuquerque
Dialysis Clinic Inc - Rio Rancho, Rio Rancho
Dialysis Clinic Inc - Boston, Boston
DaVita Boston, Boston
Dialysis Clinic Inc - Walden Pond Clinic, Concord
Dialysis Clinic Inc - Faulkner, Jamaica Plain
Dialysis Clinic Inc - Somerville, Somerville
Tufts Medical Center
OTHER
Medical University of South Carolina
OTHER
University of Pittsburgh Medical Center
OTHER
The Cleveland Clinic
OTHER
Case Western Reserve University
OTHER
University of New Mexico
OTHER